Document 3332 DOCN M94A3332 TI Restricted replication of SIVMAC239 in macrophages. DT 9412 AU Mori K; Desrosiers R; New England Regional Primate Research Center, Harvard Medical; School, Southborough, MA. SO Int Conf AIDS. 1994 Aug 7-12;10(1):10 (abstract no. 013A). Unique Identifier : AIDSLINE ICA10/94369243 AB An infectious, pathogenic, molecular clone of SIVmac239 causes AIDS and death in rhesus monkeys in a time frame suitable for laboratory investigation. This cloned SIVmac239 replicates poorly in primary macrophage cultures from rhesus monkeys. Variants with high replicative capacity for macrophages emerge in about 40% of rhesus monkeys that die with AIDS following infection with this cloned virus. Changes of 67V-->M, 176K-->E, and 382G-->R within envelope were shown to be primarily responsible for the markedly increased replicative capacity for macrophages in three independent cases that were examined. Measurement of early events demonstrated that restricted replication of SIVmac239 in macrophages was not due to initial restricted entry. This was somewhat surprising since the restricted replication was env-determined. SIVmac239 RNA levels increased normally for the first 72 hours in macrophages but then subsequently declined. Careful inspection of the kinetics of virus production suggested that SIVmac239 is produced in normal amounts for the initial 2-4 days following infection but that production subsequently declines. After 2 or more days of infection, macrophages were found to restrict entry and reverse transcription of SIVmac239 but not of the variants with high replicative capacity for macrophages. These results suggest that variants with high replicative capacity for macrophages are insensitive to an antiviral state that develops in macrophage cultures following infection. DE Animal Cells, Cultured Macaca mulatta/*MICROBIOLOGY Macrophages RNA, Viral Simian Acquired Immunodeficiency Syndrome/*MICROBIOLOGY SIV/*GROWTH & DEVELOPMENT/GENETICS Transcription, Genetic Viral Envelope Proteins *Virus Replication MEETING ABSTRACT SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).